Salient Pharmaceuticals' Angel Round

Salient Pharmaceuticals raised a round of funding on April 07, 2008. Investors include Houston Angel Network.

Salient Pharmaceuticals is a life science company developing a proprietary compound intended for use in treating severe diarrhea associated with chemotherapy, chronic conditions, infectious diseases a…

Articles about Salient Pharmaceuticals' Angel Round: